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ABSTRACT
The  Doctoral  Program  in  Molecular  Medicine  combines  systematic  doctoral
education of the highest quality to the best research expertise in molecular
medicine at the A. I. Virtanen Institute for Molecular Sciences and Department of
Medicine  in  the  Faculty  of  Health  Sciences  in  the  University  of  Eastern  Finland.
The doctoral students of the school work as active researchers in the participating
research groups whose scientific activities belong to six research programs:
Cardiovascular Diseases, Type 2 Diabetes and Cardiovascular Diseases, Type 2
Diabetes and Obesity, Neurodegenerative Diseases, Stem Cell Research, and
Inflammatory States.
This  book compiles  the abstracts  of  the 6th Annual  Post-Graduate  Symposium of
the Doctoral Program in Molecular Medicine to be held in Tahkovuori, Nilsiä, on
March 13 – 14, 2012.
Universal Decimal Classification: 577
National Library of Medicine Classification: W 20.5, QU 4, QZ 52, WG 120, WL
140, WL 359, WL 385, WK 810, QY 58, WN 185
Medical Subject Headings: Biomedical Research; Congresses; Molecular Biology;
Gene Therapy; Genetic Vectors; Gene Transfer Techniques; Glioma/therapy;
Vascular Endothelial Growth Factor; Collagen; Diabetes Mellitus, Type 2; Insulin;
Sirtuins; Cardiovascular Diseases; Epilepsy; Neurodegenerative Diseases/therapy;
Alzheimer Disease; Amyotrophic Lateral Sclerosis; Disease Models, Animal;
Magnetic Resonance Imaging; Microarray Analysis; Signal Transduction.
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6DOCTORAL PROGRAM IN MOLECULAR MEDICINE
WINTER SCHOOL 2012
MARCH 13 – 14, TAHKOVUORI NILSIÄ
PROGRAM
Tuesday, March 13
8:00 Departure from Bioteknia 1 (Neulaniementie 2)
9:00 – 9:30 Coffee, Poster set up
9:30 – 9:45 Opening of the Symposium, DPMM Vice Chair Hilkka Soininen
9:45 – 11:45 ORAL SESSION I
Chairs: Lakshman Puli and Timo Sarajärvi
9:45 – 10:05 Alzheimer’s disease – From genes to function and potential
therapies Annakaisa Haapasalo
10:05 – 10:20 Genetic and functional elucidation of GGA3 in Alzheimer’s
disease pathogenesis Teemu Natunen
10:20 – 10:35 High fat diet increases four-repeat tau expression in the brain
tissue of mice with combined T2DM and AD phenotype Mari
Takalo
10:35 – 10:50 SFRS10 as a regulator of MAPT alternative splicing in obesity
Dorota Kaminska
10:50 – 11:00 Break, exhibition
11:00 – 11:15 Can stimulation of brain recovery by enriched environment
prevent epileptogenesis after TBI? Olena Shatillo
11:15 – 11:30 Spontaneous seizures in mice carrying APP arctic mutation Sofya
Ziyatdinova
11:30 – 11:45 UEF Graduate School Anu Liikanen
11:45 – 12:30  LUNCH & EXHIBITION
12:30 – 16:00 CHECK IN, OUTDOOR ACTIVITIES
16:00 – 17:00 POSTER SESSION, COFFEE & EXHIBITION
17:00 – 18:30 ORAL SESSION II
Chairs: Emilia Kansanen and Nicholas Downes
17:00 – 17:20 Good viruses for bad diseases Kari Airenne
17:20 – 17:35 Lentiviral protein transduction with genome-modifying integrase-
I-PpoI fusion protein Vesa Turkki
17:35 – 17:50 Endothelial lipase is regulated by sterol regulatory element-
binding proteins (SREBPs) in endothelial cells Marike H. Dijkstra
17:50 – 18:00 Quantitative, multiplexed western blot detection with infrared
18:00 – 18:15 Nrf2 deficiency in LDL-receptor deficient mice expressing only
ApoB100 leads to severe atherosclerosis and occlusive coronary
artery disease Anna-Kaisa Ruotsalainen
18:15 – 18:30 Effect of soluble vascular endothelial growth factor 3 (sVEGFR3)
on atherogenesis in LDLR-/-/ApoB100/100 mouse model Taina
Vuorio
20:00 DINNER
 Isto Jänönen, Fisher Scientific fluorescence
7DOCTORAL PROGRAM IN MOLECULAR MEDICINE
WINTER SCHOOL 2012
MARCH 13 – 14, TAHKOVUORI NILSIÄ
PROGRAM
Wednesday, March 14
7:00 – 8:20 Breakfast
8:30 – 9:45 ORAL SESSION III
Chairs: Ekaterina Savchenko and Yuriy Pomeshchik
8:30 – 8:50 The Search for clinically relevant animal models of neurological
diseases Jari Koistinaho
8:50 – 9:05 Gender-specific mechanism of synaptic impairment and its
prevention by GCSF in a mouse model of amyotrophic lateral
sclerosis Eveliina Pollari
9:05 – 9:20 Interleukin-33 diminishes the lesion size in the mouse model of
permanent ischemia Paula Korhonen
9:20 – 9:35 Intra-arterial infusion of human bone marrow derived
mesenchymal cells results in transient entrapment in the brain
after cerebral ischemia in rats Bhimashankar Mitkari
9:35 – 9:45 How to create a transgenic or knockout rat in less than 6 months
Marko Sankala, Sigma-Aldrich
9:45 – 10:30 BREAK, POSTER SESSION AND EXHIBITION
10:30 – 11:25 ORAL SESSION IV
Chairs: Maija Vaittinen and Shalem Raju Modi
10:30 – 10:45 Regulation of insulin secretion in sulfonylurea receptor 1 knock-in
mouse Nagendra Yaluri
10:45 – 11:00 Hippocampal volume, tensor-based morphometry and voxel-
based morphometry in Frontotemporal dementia Miquel Muñoz
11:00 – 11:15 Cortical spreading depression investigated using spin-lock
functional magnetic resonance imaging Joonas Autio
11:15 – 11:25 Targeted Resequencing Solutions from Illumina Reija Laitinen,
Illumina
11:25 – 12:40 LUNCH AND EXHIBITION
812:40 – 14:15 ORAL SESSION V
Chairs: Heidi Laitinen and Tomi Tuomainen
12:40 – 13:00 Hypoxia response pathway as a potential therapeutic target
Johanna Myllyharju, BCO
13:00 – 13:15 Interferon  sensitivity of tumor cells correlates with poor
response to VA7 virotherapy in mouse glioma models Janne
Ruotsalainen
13:15 – 13:30 The effect of knockdown of XIAP in a switch from Type II to Type
I TRAIL signaling in human follicular lymphoma cells Jemal
Adem
13:30 – 13:45 Characterization of hNPC derived from hES and hiPS cells
injected into intact and injured spinal cord Iurii Kidin
13:45 – 14:00 Preventing atherosclerosis with IK17-antibody in mice Antti
Määttä
14:00 – 14:15 Selection of tumor and tumor vasculature specific antibodies from
phage display library and their genetic delivery in vivo Emmi
Kokki
14:15 – 14:45 COFFEE
14:45 – 15:00 Awards committee
Best presentations
Director of the DPMM, Best doctoral thesis
Closing of the symposium
15:00 – Departure
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PROGRAM
POSTERS
1. Conformational regulation of 1 integrin and its effects on cell adhesion
and signaling Henri Niskanen
2. Inflammatory cells and pain transducers in rat meninges Juha Ropponen
3. Molecular mechanisms of seladin-1 in pathways relevant for Alzheimer’s
disease pathogenesis Henna Martiskainen
4. Development of a cell-permeable peptide that acts downstream of nNOS to
protect neurons against excitotoxicity Lili Li
5. Post-traumatic epileptogenesis in APP/PS1 mouse model with amyloidogenic
APP processing Diana Miszczuk
6. Loss of hippocampal parvalbumin immunoreactivity during epileptogenesis
Noora Huusko
7. T1rho MRI for evaluation of VEGF-B angiogenic therapy Haja-Sherief N.
Mustafa
8. Attenuation of lethal semliki forest virus neurovirulence in mice by neuronal
microRNA targeting Miika Martikainen
9. Expression of microfibrillar-associated protein 5 (MFAP5) is differently
modified by inflammatory factors in adipocytes Maija Vaittinen
10. Nuclear factor (erythroid-derived 2)-like 2 regulates neurogenesis in adult
hippocampus after brain injury Ekaterina Savchenko
11. Early detection of VEGF gene therapy response in ischemic hind limb mouse
model by MRI rotating frame relaxation Hanne Hakkarainen
12. Novel diffusion based MRI contrast based on double pulsed field gradients
Tuukka Miettinen
13. A Novel method to separate various phenotypes of microglia Lakshman Puli
14. Characterization of novel PGC1alpha isoforms Heidi Laitinen
15. Implementation of pharmacological MRI Jaakko Paasonen
16. Effect of hypoxia on the physiology of developing cardiomyocytes Tomi
Tuomainen
17. Utilizing Galaxy framework for sequence data preprocessing in lentivirus
vector integration site analysis Oskari Timonen
18. Adeno-associated virus mediated gene transfer to mouse myocardium –
transduction efficiency and effect on left ventricular function Line Lottonen
10
11
Oral Session I
Chairs:
– Lakshman Puli & Timo Sarajärvi –
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GENETIC AND FUNCTIONAL ELUCIDATION OF GGA3 IN ALZHEIMER’S
DISEASE PATHOGENESIS
Teemu Natunen [1], Seppo Helisalmi [1], Juha-Pekka Pursiheimo [2], Timo Sarajärvi [1], Petra
Mäkinen [1], Anne-Maria Koivisto [1], Irina Alafuzoff [3], Annakaisa Haapasalo [1], Hilkka
Soininen [1] and Mikko Hiltunen [1]
[1] Institute of Clinical Medicine - Neurology, University of Eastern Finland and Department of Neurology,
Kuopio University Hospital; [2] Turku Centre for Biotechnology, University of Turku, Finland; [3] Department
of Immunology, Genetics and Pathology, Uppsala University, Sweden
Alzheimer’s disease (AD) is a neurodegenerative disorder with genetically
complex background. Aggregation of amyloid- peptide (A) and hyper-
phosphorylated tau protein are key neuropathological hallmarks in AD brain. -
secretase (BACE1) protein is an initial and rate-limiting enzyme in the production
of A, while GGA3 (Golgi-localized -ear-containing ARF-binding protein) is a
transport  protein,  which  has  been  shown  to  affect  the  degradation  of  BACE1.
Here, we assessed the genetic and functional role of GGA3 in AD using clinic-
based case-control and neuropathological AD sample sets. Six single nucleotide
polymorphisms in GGA3 gene  were  genotyped  among  673  AD  patients  and  686
controls. APOE-, gender-, and age-adjusted logistic regression analyses revealed a
decreased risk of AD by ~30% for A allele carriers of rs2242230 as compared to
non-carriers.  Comparison  of  mRNA  and  protein  levels  of  GGA3  with  respect  to
the severity of AD pathology or GGA3 genotype  (GG  vs.  GA)  did  not  reveal
significant alterations in the inferior temporal cortex samples of AD patients.
Although the genetic study revealed a significant association with GGA3 variation,
further studies are needed to fully establish the genetic and functional role of
GGA3 in AD.
HIGH FAT DIET INCREASES FOUR-REPEAT TAU EXPRESSION IN THE
BRAIN TISSUE OF MICE WITH COMBINED T2DM AND AD PHENOTYPE
Mari Takalo [1], Annakaisa Haapasalo [1], Susanna Kemppainen [2], Petra Mäkinen [1], Hilkka
Soininen [1], Markku Laakso [3], Heikki Tanila [2], Mikko Hiltunen [1]
[1]Institute of Clinical Medicine – Neurology, [2] A.I. Virtanen Institute, and [3] Institute of Clinical Medicine -
Medicine, University of Eastern Finland
Based on the numerous epidemiological studies, type-2 diabetes mellitus (T2DM)
increases the risk of Alzheimer’s disease (AD). However, molecular mechanisms
underlying this co-morbidity are not well understood. Intraneuronal deposits of
microtubule-associated protein tau are a common feature of several
neurodegenerative diseases, including AD. Moreover, aberrant splicing of tau
exon 10 leads to the altered ratio of four-repeat (4R) vs. three-repeat (3R) isoforms
in neurodegenerative diseases. To investigate the effects of both genetic and high
fat-induced diabetic phenotype on tau pathology, we used a well-characterized
AD mouse model with hyperglycemia induced by the over-expression of
pancreatic insulin-like growth factor 2. High fat diet induced up to five-fold
increase  in  4R  tau  expression  in  the  ventral  cortex  of  female  mice.  Although  the
expression  of  3R  tau  was  also  induced,  the  ratio  of  4R  vs.  3R  isoforms  was
significantly increased on average two-fold. These changes were independent of
the genotype. This study provides experimental in vivo evidence that high fat diet
can  alter  tau  exon  10  splicing,  which  in  turn  may  ultimately  modulate  tau
pathology. Finally, these results suggest that tau-related pathological mechanisms
can be affected by active dietary choices.
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SFRS10 AS  A  REGULATOR  OF MAPT ALTERNATIVE SPLICING IN
OBESITY
Dorota Kaminska [1,2], Sari Venesmaa [3], Pirjo Käkelä [3], Maija Vaittinen [2], Leena Pulkkinen
[2], Helena Gylling [2], Markku Laakso [1] and Jussi Pihlajamäki [1,2]
Departments of [1] Medicine and [2] Clinical Nutrition, University of Eastern Finland; [3] Department of
Surgery, Kuopio University Hospital
We have recently published that expression of splicing factor SFRS10 is reduced in
liver  and  muscle  of  obese  humans  and  that SFRS10 contributes to increased
lipogenesis and lipid accumulation due to altered splicing of exon 6 of LPIN1.
Moreover, SFRS10 is known to regulate alternative splicing of human microtubule
associated  protein  tau  (MAPT)  gene.  In  this  study  we  investigate  the  role  of
SFRS10 in alternative splicing of MAPT in  adipocytes,  determined  by  PCR
capillary electrophoresis. Our hypothesis is that MAPT may alter microtubules
function in adipocytes, as shown in neurons, and regulate adipocyte metabolism.
We observed that MAPT exon 10 splicing correlates with the SFRS10 mRNA
expression in subcutaneous and visceral fat (p< 0.05). Lack of exon 10 is associated
with type 2 diabetes in both fat depots (p< 0.005). Finally, we observed an
association between inclusion of MAPT exon 10 and serum free fatty acid level in
subcutaneous and visceral fat tissue of obese individuals (p< 0.05), suggesting a
physiological role of MAPT in adipose tissue. Our future plans include testing the
effect of SFRS10 siRNA on alternative splicing of MAPT, Tau phosphorylation and
cell metabolism  in SGBS cell line.
CAN STIMULATION OF BRAIN RECOVERY BY ENRICHED
ENVIRONMENT PREVENT EPILEPTOGENESIS AFTER TBI?
Olena Shatillo [1], Jukka Jolkkonen [2], Asla Pitkänen [1]
[1] Department of Neurobiology, University of Eastern Finland; [2] Institute of Clinical Medicine – Neurology
Traumatic brain injury (TBI) is a cause of 10-20% cases of symptomatic epilepsies.
It was shown that enriched environment (EE) enhances motor and cognitive
recovery after TBI in rats. The aim of the present work was to determine effect of
EE on the development of lowered seizure threshold after TBI, and to correlate it
with motor and cognitive recovery. To study posttraumatic epileptogenesis lateral
fluid percussion TBI was performed in 2 groups of male Sprague-Dawley rats.
One group of TBI rats (n=7) and corresponding sham-operated group (n=3) were
housed in standard conditions. Second TBI group (n=8) and sham control (n=3)
were placed in the EE. Behavior tests (neuroscore, beam-walking and Morris water
maze) were done at 5 different time points (2d, 1wk, 2wk, 4wk, 8wk) to investigate
posttraumatic recovery. Continuous 1 week video-EEG recording was performed
3 month after TBI. Then seizure threshold was tested with pentyleneterazol (25
mg/kg),  followed  by  24h  video-EEG  recording.  Results  show  that  EE  was  not
beneficial for functional recovery. We found increase (p0,05) in number of
spontaneous epileptiform discharges in TBI animals with EE compared to
standard conditions during 1 week video-EEG monitoring. It implies that EE
rather facilitates epileptogenesis then prevents it.
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SPONTANEOUS SEIZURES IN MICE CARRYING APP ARCTIC MUTATION
Sofya Ziyatdinova [1], Annica Rönnbäck [2], Caroline Graff [2], Bengt Winblad [2], Asla Pitkänen
[1,3], and Heikki Tanila [1,3]
[1] A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland; [2] Karolinska Institutet; [3]
Kuopio University Hospital
The Arctic mutation (E693G) of amyloid precursor protein (APParc) causes early
onset autosomal dominant dementia. Mice with single Arctic APP mutation have
cognitive dysfunction and amyloid  deposition, starting in the subiculum at 4
month of age. Arctic APP mutation increases formation of amyloid  protofibrils,
without increasing amyloidogenic - and -secretase cleavage of APP. We aim to
verify suspected presence and characteristics of seizure activity in APParc mice. 21
homozygous APParc tg female mice and their 11 wt littermates were implanted
with cortical electrodes. 3 video-EEG sessions (24/7, 2 wk) were performed at age
of 15-20 wk, 23-24 wk and 32-35 wk. The behavioral phenotype of the seizure was
assessed with Racine’s scale. At the age of 15-20 wk seizures were observed in
6/21 (29%) APParc tg mice and in 2/11 (18%) wt mice. At age of 23-24 wk,
seizures were observed in 6/20 (30%) APParc tg (2 mice with new-onset seizures)
and in 2/11 (18%) wt (2 mice with new-onset seizures). Seizure frequency was 1
seizure per  2  wk,  seizure duration in  APParc  tg  mice  was 18±10 sec  in  Session 1
and longer (33±17 sec, p<0.05) in Session 2. Our data confirm occurrence of
spontaneous epileptic seizures in tg APParc mice that is possibly related with the
presence of soluble A protofibrils.
15
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CONFORMATIONAL REGULATION OF 11 INTEGRIN AND ITS
EFFECTS ON CELL ADHESION AND SIGNALING
Henri Niskanen, Johanna Jokinen, Jarmo Käpylä and Jyrki Heino
Department of Biochemistry & Food Chemistry, University of Turku
11 integrin belongs to the collagen receptor family of integrins, which regulate
cell adhesion, migration and proliferation and have significant roles in many
diseases, for example in cancer, thrombosis and inflammation. Our studies
focused on the activation of 11 integrin and how structural changes regulate its
function on cellular level. We introduced site specific mutations to 1 integrin and
produced CHO cell lines expressing 1 integrin variants. Cell adhesion on type I
and IV collagens was monitored with real time cell analyzer, confocal and live
microscopy. We also investigated the effects of these mutations on integrin-
mediated signaling pathways, for example ERK and Rho GTPases. Cell adhesion
on  type  I  and  IV  collagens  was  enhanced  when  ligand  binding  1I domain was
activated with mutation E317A. Mutation E335A, which disrupts allosteric
regulation between  and  subunits, prevented cell adhesion, as expected.
Interestingly the double variant E317A/E335A expressing cells were able to attach
on type IV collagen, but their spreading was partially prevented. 1 integrin was
also able activate ERK signaling even in presence of inactivating mutation E335A.
Our results suggest that activation mechanisms of collagen receptor integrins
might differ from other integrins.
INFLAMMATORY CELLS AND PAIN TRANSDUCERS IN RAT MENINGES
Juha Ropponen [1], Giedrius Kalesnykas [2], Dmitriy Fayuk [1] and Rashid Giniatullin [1]
[1] Dept Neurobiology, AIVI, University of Eastern Finland; [2] Dept Ophthalmology, University of Eastern
Finland
Migraine is the most common neurological disease associated with aseptic
neuroinflammation around blood vessels in meninges. It has been suggested that
the severe migraine headache originates from meninges but the final proof of the
peripheral basis and the mechanism of pain transduction remains unclear. In the
current project we analyzed the distribution of mast cells, suspected players in
migraine, using staining of rat dura mater with Toluidine Blue and performed live
imaging of meningeal cells loaded with the calcium fluorescent dye, Fluo-3AM.
We show here that mast cells are abundantly expressed in meninges and their
number was increased after induction of migraine-like states with the NO donor.
Intracellular Ca2+ imaging allowed us to visualize meningeal vessels and other
residual  meningeal  cells  in  control  and  after  application  of  the  P2X  and  TRPV1
agonists, ATP and capsaicin, respectively. We obtained experimental evidence that
application of ATP little changed the diameter of meningeal vessels but induced
Ca2+ waves in dura mater cells while capsaicin induced strong vasoconstriction.
Immunogold/P2X3 labeling of dura mater indicated that pain transducing P2X3
receptors were localized in meningeal nerves. Thus, the combination of various
imaging  technique  allowed  us  to  track  the  dynamics  of  meningeal  cells  and
indicated expression of pain transducers in dura mater. Taken together these data
support the hypothesis of peripheral origin of migraine pain.
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MOLECULAR MECHANISMS OF SELADIN-1 IN PATHWAYS RELEVANT
FOR ALZHEIMER’S DISEASE PATHOGENESIS
Henna Martiskainen, Timo Sarajärvi, Petra Mäkinen, Annakaisa Haapasalo, Hilkka Soininen,
Mikko Hiltunen
Institute of Clinical Medicine – Neurology, University of Eastern Finland
Seladin-1/DHCR24 is neuroprotective protein, which is selectively down-
regulated in the brain regions affected in Alzheimer’s disease (AD). Seladin-1
confers resistance against A- and oxidative stress-induced apoptosis and
decreased levels of seladin-1 lead to the increased -amyloidogenic processing of
APP in the apoptotic conditions. Collectively, these data suggest that seladin-1 has
an important role in the AD pathogenesis. Here, we investigated whether the
over-expression of seladin-1 has beneficial effects on pathways relevant for AD,
such as APP processing and A-generation in human neuroblastoma SH-SY5Y
cells over-expressing APP751 isoform (SH-SY5Y-APP751). SH-SY5Y-APP751 cells
were transfected with seladin-1 plasmid and total protein lysates as well as cell
culture medium samples were analyzed using Western blotting and A-ELISA.
Over-expression of seladin-1 significantly increased the levels of total APP on
average 1.6-fold. Conversely, total APP normalized APP CTF levels were
decreased, which again coincided with the decreased A40 and A42 levels in the
cell culture medium. These results suggest that elevated seladin-1 expression in
neuronal cells may exert beneficial effects on APP processing by reducing the A
generation.
DEVELOPMENT OF A CELL-PERMEABLE PEPTIDE THAT ACTS
DOWNSTREAM OF nNOS TO PROTECT NEURONS AGAINST
EXCITOTOXICITY
Lili Li [1], Xiaonan Liu [1], Olga Vergun [1], Vanessa Ginet [2], Anita Truttmann [3], Michael J.
Courtney [1]
[1] Dept. of Neurobio., University of Eastern Finland; [2] DBCM, Univ. de Lausanne; [3] Dept. of Pediatrics and
Pediatric Surgery, CHUV, Lausanne, Switzerland
The scaffold protein PSD95 assembles a ternary complex with the NMDA receptor
subtype  (NR)  and  neuronal  nitric  oxide  synthase  (nNOS).  We  found  that  rapid
activation of p38MAPK by NR-gated calcium requires the catalytic activity of
nNOS and early  p38 activity  is  required for  cell  death.  We have investigated the
excitotoxicity-evoked activation mechanism and identified a region of nNOS,
which when expressed, reduces excitotoxicity but without effect on either NO
production or calcium elevation. This finding suggests that excitotoxic signaling
downstream of NO may require a previously unidentified downstream binding
partner of the region. We therefore designed a cell-permeable peptide (CPP) which
binds to this region in order to compete with its endogenous interacting partners.
The CPP inhibits excitotoxic activation of p38 in cortical cultures, consistent with
an action downstream of NO. In an animal model of neonatal hypoxia-ischaemia,
the CPP enters neuronal cells, reduces p38 activity and doubles surviving tissue,
exhibiting as much reduction in lesion size as a p38 inhibitor. These results suggest
not only the CPP is a novel neuroprotectant but also that excitotoxic activation of
p38 downstream of NO requires nNOS-binding partners that are yet to be
identified.
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POST-TRAUMATIC EPILEPTOGENESIS IN APP/PS1 MOUSE MODEL WITH
AMYLOIDOGENIC APP PROCESSING
Diana Miszczuk [1,2], Heikki Tanila [1], Katarzyna Lukasiuk [2], Asla Pitkänen [1]
[1] A. I. Virtanen Institute, University of Eastern Finland; [2] The Nencki Institute of Experimental Biology,
Polish Academy of Science
Growing evidence suggests an association between Alzheimer disease (AD) and
epilepsy. It has been showed that 65% of APP/PS1 mice display at least one
seizure  by  the  age  of  5  months.  To  address  the  question  whether  increased
amyloid load facilitates post-traumatic epileptogenesis we induced traumatic
brain injury (TBI) in 13-15wk old APP/PS1 mice and Wt littermates. Long-term
(24/7) 2-wk EEG recording was performed starting at 6 and 14wk post-TBI. AD
injured showed motor deficits compared to AD controls at 2d (p<0.01), 7d (p<0.01)
and 14d post-TBI (p<0.05). AD injured were more impaired than Wt injured at 14d
post-TBI (p<0.01). Latency to find the platform in MWM was longer in AD injured
than in Wt injured group (p<0.05). There was no difference in EEG results between
groups. 1stEEG showed spontaneous seizures in AD injured and AD controls (43%
of  each  group).  Epileptiform  discharges  (EDs)  were  observed  in  29%  of  AD
controls. In 2ndEEG seizures and EDs continued in AD controls (25%) and
occurred as well in Wt injured (14%). AD injured mice displayed more behavioral
alterations than Wt injured and AD controls. Epileptiform activity started from
2ndEEG  in  Wt  injured  suggests  that  longer  follow-up  or  increase  injury  severity
may reveal whether TBI facilitates epileptogenesis in AD mice.
LOSS OF HIPPOCAMPAL PARVALBUMIN IMMUNOREACTIVITY DURING
EPILEPTOGENESIS
Noora Huusko, Christine Römer, Asla Pitkänen
Epilepsy Research Laboratory, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland,
Finland
Parvalbumin (PARV) labels about 20 % of GABAergic interneurons which are
responsible for inhibition to principal cells. Impaired function of inhibition is
presumed to contribute to seizure susceptibility. To address a question, whether
the severity  of  damage to  PARV positive  neurons depends on the type of  insult,
we compared the number of cells at 1 and 6 months after status epilepticus (SE) and
traumatic brain injury (TBI) in rats.  Presence of seizures was investigated with v-
EEG  at  6  months  post-insult  and  TBI  rats  also  underwent  test  of  seizure
susceptibility. Decrease of PARV positive cells depends on etiology being greatest
at 6 months post-TBI in ipsilateral dentate gyrus (35 % of cells remaining, p<0.001).
Rats  in  this  group had lowered seizure threshold but  no seizures.  Unexpectedly,
the loss  of  PARV positive  neurons (84  % of  cells  remaining,  p>0.05)  in  rats  with
post-SE epilepsy is much milder than in the TBI group and not associated with
seizure frequency.  However,  lower the number of  PARV positive  neurons in  the
contralateral  granule  cell  layer,  longer  the  duration  of  spontaneous  seizures.  In
conclusion, reduced number of PARV positive cells can contribute to seizure
susceptibility, but it is not necessarily associated with occurrence of seizures.
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T1RHO MRI FOR EVALUATION OF VEGF-B ANGIOGENIC THERAPY
Haja-Sherief N. Musthafa, L Lottonen, S Ylä-Herttuala,O Gröhn, T Liimatainen
 A.I. Virtanen Institute, University of Eastern Finland, Kuopio
The possibility of creating new blood vessels in ischemic heart has lead to many
angiogenic preclinical trials involving delivery of vascular endothelial growth
factor for treatment of myocardial ischemia. VEGF-B167 has been used in previous
experiments to reduce the structural and functional disorder of cardiac muscle in
dilated cardiomyopathy (DCM) and preserve contractility of heart muscles. In this
research,  we  used  MRI  methods  such  as  spin  lattice  relaxation  time  (T1rho),  &
spin-spin relaxation time (T2) to monitor gene therapy response in mouse models
of DCM which are formed by a myocardial specific promoter Myosin heavy chain
alpha transgenic strain. We used seven transgenic mice (MHCA-VEGFB) and five
wild type mice which were imaged at 9.4 T. T1rho, T2 weighted and cine images
were  acquired  on  5th,  7th and 10th months.  A  significant  difference  was  found  in
T1rho between 5th and 10th months in transgenic mice (*p=0.025). The mean left
ventricle mass of the transgenic mice was found to be larger (124.3±12.9) than that
of control mice (107.7±3.3) (*p=0.04) in 10th month. No significant differences were
found  in  stroke  volume,  ejection  fraction,  cardiac  output,  end  systolic  and  end
diastolic volumes. The research will be continued for more time periods and
monitor the gene therapy response.
ATTENUATION OF LETHAL SEMLIKI FOREST VIRUS NEUROVIRULENCE
IN MICE BY NEURONAL MICRORNA TARGETING
Miika Martikainen [1], Erkko Ylösmäki [2], Ari Hinkkanen [1], Kalle Saksela [2]
[1] A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland; [2] Haartman Institute,
University of Helsinki
MicroRNAs (miRNAs) are small non-coding RNA molecules that have important
regulatory  roles  in  gene  expression  by  targeting  mRNAs  for  cleavage  or
translational repression.  The miRNA machinery has recently been successfully
exploited  to  modify  tropism  of  both  RNA  and  DNA  viruses  to  prevent  viral
replication in specific unwanted tissues. Semliki forest virus (SFV) is an enveloped
positive-strand RNA virus of the family Togaviridae. SFV strains such as SFV4 and
L10 are highly neurovirulent in mice of all ages causing fatal encephalitis while
avirulent strain A7(74) is attenuated in the central nervous system (CNS) of adult
mice.  Replicative  SFV  vectors  based  on  strain  A7(74)  have  been  shown  as
promising tools for oncolytic virotherapy with particular interest in therapy of
brain  tumours.  To  further  increase  the  safety  of  SFV  virotherapy,  additional
measures to restrict SFV replication in the CNS are needed. We have generated
miRNA-targeted SFV vectors by inserting target elements for neuron-specific
miRNAs into the SFV genome. Results indicate that SFV carrying target elements
for miR124 has significantly attenuated replication potency in the CNS of Balb/c
mice while retaining oncolytic properties in vitro.
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EXPRESSION OF MICROFIBRILLAR-ASSOCIATED PROTEIN 5 (MFAP5) IS
DIFFERENTLY MODIFIED BY INFLAMMATORY FACTORS IN
ADIPOCYTES
Maija Vaittinen [1], Marjukka Kolehmainen [1], Mikael Rydén [2], Matti Eskelinen [3], Martin
Wabitsch [4], Matti Uusitupa [1], Leena Pulkkinen [1]
[1] Clinical Nutrition, Univ. of Eastern Finland; [2] Karolinska Univ. Hospital, Sweden; [3] Kuopio Univ.
Hospital, Finland; [4] Univ. of Ulm, Germany
We  have  earlier  shown  that  the  expression  of  MFAP5  is  down-regulated  in
adipose tissue (AT) along with weight reduction in the persons with metabolic
syndrome (The Genobin study). Our aim was to study the role of MFAP5 in
cultured human SGBS adipocytes to examine if inflammatory factors regulate the
MFAP5 mRNA expression in preadipocytes and mature SGBS adipocytes.
Immunohistochemistry of human AT and the gene expression pattern in SGBS
cells  showed  that  MFAP5  was  highly  expressed  in  AT  and  its  expression  was
decreased during preadipocyte differentiation. Furthermore, down-regulation of
the  MFAP5  mRNA  by  siRNA  resulted  in  a  reduction  of  several  genes  related  to
extracellular matrix (ADAM12, NOTCH1) and inflammation (TGF1, IL1, IL-6).
Treatment  of  mature  adipocytes  with  TGF1,  TNF-,  IL1 or  IL-6  decreased  the
mRNA expression of MFAP5, and treatment with IL1 or the highest (10 ng/ml)
TNF- concentration decreased the expression of MFAP5 in preadipocytes,
whereas a treatment of preadipocytes with TGF1, IL-6 or the lowest (0.1 ng/ml)
TNF- concentration increased the MFAP5 mRNA expression. These results
suggest that inflammatory factors which facilitate low-grade inflammation and
promote insulin resistance in obesity modulate the expression of MFAP5 in
adipocytes.
NUCLEAR FACTOR (ERYTHROID-DERIVED 2)-LIKE 2 REGULATES
NEUROGENESIS IN ADULT HIPPOCAMPUS AFTER BRAIN INJURY
E. Savchenko, Y. Pomeshchik, H. Dhungana, V. Karkkainen, T. Malm, J. Koistinaho
Department of Neurobiology, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland
The  generation  of  new  neurons  within  the  dentate  gyrus  of  the  mature
hippocampus is critical for spatial learning, object recognition and memory. Free
radical damage is one of the main contributory factors of impaired neurogenesis in
chronic neurodegenerative diseases. Transcription factor nuclear factor E2-related
factor 2 (Nrf2) has been shown to be central for protection against oxidative stress
by binding to the antioxidant response element (ARE) enhancer sequence of
numerous  protective  genes.  Using  Nrf2  (Nrf2-/-) deficient mice, we assessed the
importance of Nrf2 in neurogenesis within the hippocampus after seizures or
global ischemic injury. Seizure induction with kainic acid as well as global
ischemia resulted in elevated doublecortin (DCX) expression, a marker of
neurogenesis, and Ki-67 expression (marker of cell proliferation) both in wild-type
(wt) and Nrf2-/- mice in comparison with vehicle-treated mice in dentate gyrus of
hippocampus. Relative to wt mice, Nrf2-/- mice showed significantly fewer DCX+
and Ki-67+ cells. This finding suggests that Nrf2 is important for proliferation of
progenitor  neural  cells  in  the  dentate  gyrus  in  response  to  brain  injury.  We
hypothesize that pharmacolocigal or gene therapy promoting Nrf2 expression
increases neurogenesis in the hippocampus and is beneficial after brain injury.
21
EARLY DETECTION OF VEGF GENE THERAPY RESPONSE IN ISCHEMIC
HIND LIMB MOUSE MODEL BY MRI ROTATING FRAME RELAXATION
Hanne Hakkarainen [1], Galina Dragneva [1], Seppo Ylä-Herttuala [1], Olli Gröhn [2],
Timo Liimatainen [1]
[1] Department of Biotechnology and Molecular Medicine, University of Eastern Finland; [2]
Department of Neurobiology, University of Eastern Finland
Current knowledge of potential non-invasive MRI markers to detect therapy
response in ischemic skeletal muscle is limited. However, the longitudinal
relaxation time in the rotating frame (T) has shown to be a potential quantitative
MRI marker for tissue remodeling after myocardial infarction. Relaxation Along a
Fictitious Field (RAFF) time constant TRAFF has been found to correlate with cell
density in rat glioma gene therapy model, implying that TRAFF could be a sensitive
marker of cell death in gene therapy model. The potential of rotating frame
relaxation times to detect the gene therapy response in ischemic skeletal muscle
will be studied in mouse gene therapy model of hind limb ischemia in vivo. The
mice femoral artery of single hind limb will be ligated and adenovirus mediated
vascular endothelial growth factor (VEGF-A and VEGF-D) will be injected. Lac-Z
serves as control. The mice will be imaged using 7T MRI scanner before and 0, 1, 3,
7, 14 and 28 days after ligation. T, TRAFF2 and TRAFF4,  T1,  T2 and water diffusion
will be measured. The results will be compared with histology derived severity of
infarction and ultrasound perfusion. The most potent gene therapy MRI markers
will be applied for monitoring a gene therapy response in a rabbit hind limb
ischemia model.
NOVEL DIFFUSION BASED MRI CONTRAST BASED ON DOUBLE PULSED
FIELD GRADIENTS
Tuukka Miettinen, Alejandra Sierra, Teemu Laitinen and Olli Gröhn
Department of Neurobiology, A.I. Virtanen Institute, University of Eastern Finland, PO BOX 1627, FI-
70211 Kuopio, Finland
Diffusion-based techniques are commonly used to generate contrast in Magnetic
Resonance Imaging (MRI). Diffusion Tensor Imaging (DTI) is an effective non-
invasive method to study coherently oriented white matter structures in brain.
However,  DTI  is  limited  when  tissue  is  more  randomly  oriented,  like  in  gray
matter. Novel double-pulsed-field-gradient (d-PFG) techniques may provide new
MRI contrasts, when the tissue consists of smaller and randomly oriented
structures. In this approach, two diffusion gradient pairs are applied offering
many degrees of freedom, and the diffusion periods, mixing time and the angle
between the gradient pairs can be varied. D-PFG has potential to be used in
characterization  of  axon  sizes  and  compartment  size  distribution  in  the  grey
matter.  In  the  present,  study  this  approach  will  be,  for  the  first  time,  used  to
characterize pathological changes in rat brain after traumatic brain injury. Results
will be verified using histology and electron microscopy of tissue samples.
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A NOVEL METHOD TO SEPARATE VARIOUS PHENOTYPES OF
MICROGLIA
Lakshman Puli [1], Heikki Tanila [1, 2]
[1] Department of Neurobiology, A.I.Virtanen Institute, University of Eastern Finland; [2] Department of
Neurology, Kuopio university hospital
Microglia are dynamic and help maintaining homeostasis by actively monitoring
their microenvironment. Microglia can be activated by a plethora of microbial and
aseptic stimuli. One can visually appreciate various sub-populations of microglia;
however, currently we lack analysis method to quantify such sub-populations of
microglia within a tissue. Flow cytometry segregates microglia efficiently but we
lose details of tissue microenvironments. Here, we describe a novel method of
segregating microglia based on their morphology and expression of CD45/Iba-1
markers. Coronal brain sections from transgenic Alzheimer’s mice were double
labelled with fluorescent labels for CD45 and Iba-1a. Using confocal microscope, Z
stack images of microglia were acquired and then, image J analysis software was
used to derive integrated intensities as well as circularity data from 955 microglial
cells  in  a  random  manner.  Data  when  plotted  on  3D  graph,  three  different  sub-
populations of microglia were demarcated both visually and statistically.
Investigating subpopulations of microglia in their microenvironments may reveal
their functional identities in health and disease.
CHARACTERIZATION OF NOVEL PGC1ALPHA ISOFORMS
Heidi Laitinen, Anna-Liisa Levonen, Pasi Tavi
Department of Biotechnology and Molecular Medicine, University of Eastern Finland
Peroxisome proliferator-activated receptor gamma co-activator alpha (PGC1) is a
master  regulator  of  energy  metabolism,  and  an  important  factor  in  the
maintenance  of  the  cardio-vascular  system.  Recently  four  novel  isoforms  of
PGC1 have been found that differ in structure and expression. These isoforms are
suspected to have different effects in the cardio-vascular system. The aim of this
research is  to  elucidate  the function and expression of  different  PGC1 isoforms
(PGC11-4) in cardio-vascular tissues. We study the basal and stimulated
expression of PGC1 isoforms in cardiomyocytes and endothelial cells, the
expression of PGC1 isoforms in cardiomyocytes from mice subjected to exercise
or  cardiac  pressure  overload  evoked  by  transverse  aortic  constriction  (TAC),  the
isoform specific target genes by isoform specific lentiviral overexpression in
cardiomyocytes and endothelial cells, and the effect of isoform specific AAV9
overexpression in the TAC-mice hearts. In case differences in the expression and
effects of the PGC1 isoforms in cardio-vascular tissues are found, the individual
isoforms can potentially be utilized in therapeutic applications against cardio-
vascular diseases.
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IMPLEMENTATION OF PHARMACOLOGICAL MRI
Jaakko Paasonen [1], Joanna Huttunen [1], Markus Forsberg [2], Olli Gröhn [1]
[1] Department of Neurobiology, University of Eastern Finland; [2] School of Pharmacy, University of Eastern
Finland
Pharmacological MRI (phMRI) is a modern imaging method providing indirect
information of the actions of pharmaceuticals in tissue. The conventional
functional  MRI  (fMRI)  method  for  studying  brain  activation  is  the  blood
oxygenation level dependent (BOLD) fMRI, in which changes in blood
oxygenation, flow and volume are used for localization of the activated areas. The
general idea of phMRI has been discussed for years, but several issues still remain.
These issues include weak BOLD fMRI signal changes, selection of suitable
anesthetics, controlling of animal physiology, and deficient data analysis models.
In  this  project,  the  main  focus  is  to  develop  phMRI  methodology  in  order  to
construct a robust measurement protocol and data analysis method for the use of
phMRI in preclinical drug development as well as in characterization on
experimental  disease  models.  The  goals  are  to  1)  construct  a  robust  phMRI  data
acquisition protocol, 2) incorporate pharmacokinetic model into phMRI data
analysis, and 3) characterize brain function and its recovery after brain injury
using phMRI.
EFFECT OF HYPOXIA ON THE PHYSIOLOGY OF DEVELOPING
CARDIOMYOCYTES
Tomi Tuomainen, Pasi Tavi
 Department of Biotechnology and Molecular Medicine, University of Eastern Finland
Oxygen is an important regulator of cellular differentiation. For example it has a
well-known role in vascular formation. During early developmental phases tissues
sustain remarkably lower oxygen levels than in adulthood. This is also true with
embryonic heart whereas adult myocardium is highly energetic and requires a lot
of oxygen to function properly. What is the role of oxygen tension in the
development of cardiomyocyte function? To answer this question primary
cultures of embryonic and neonatal mice cardiomyocytes are exposed to hypoxic
conditions and the effects of low oxygen on their physiolological properties are
analyzed.  Size  of  the  cells  is  assessed  with  Coulter  counter.  The  amount  of
mitochondria will be measured by flow cytometric analysis of cells stained with a
mitochondrial dye and mitochondrial function analyzed with Seahorse XF24
extracellular flux analyzer. Intracellular calcium signals are measured with line-
scanning confocal microscopy of Fluo-4 loaded cardiomyocytes. Results of this
study  will  gain  our  knowledge  in  the  development  of  cardiomyocytes.
Furthermore, findings can potentially elucidate molecular events which occur
during hypoxic stress in adult heart tissue.
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UTILIZING GALAXY FRAMEWORK FOR SEQUENCE DATA
PREPROCESSING IN LENTIVIRUS VECTOR INTEGRATION SITE
ANALYSIS
Oskari Timonen [1], Vesa Turkki [1,2], Seppo Ylä-Herttuala [1]
[1] Department of Molecular Medicine and Biotechnology, AIVI, University of Eastern Finland; [2] Ark
Therapeutics group Plc.
Integration  site  analysis  is  an  important  part  in  risk  assessment  of  gene  therapy
concerning retro- and lentivirus vectors. Distribution of integration sites in host
genome gives valuable information on safety and effectiveness of used vectors.
Easily reproducible way for determining integration sites from high-throughput
sequence data may possess a challenge by itself. Sequences need to be filtered and
cleaned up to the point where sequences that are left only contain host’s genomic
DNA.  These  sequences  can  then  be  cross-referenced  to  appropriate  genome  in
order  to  determine  integration  sites  of  the  vector.  Galaxy  platform  provides  an
accessible and reproducible way for this kind of computationally multilayered
processing and analysis of genomic data. Custom tools programmed for specific
purpose  may  also  be  incorporated  as  a  part  of  local  instance  of  the  galaxy
platform. 454 sequence data from lentivirus transduced cells was preprocessed
using  Galaxy  with  an  integrated  custom  tool  for  deleting  the  adapter  sequences
and  everything  after  or  before  a  specific  sequence.  Such  tool  was  programmed
using  Perl  and  BioPerl  modules  which  then  could  be  incorporated  as  a  part  of
Galaxy workflow along with other operations needed for the preprocessing step.
ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO MOUSE
MYOCARDIUM –TRANSDUCTION EFFICIENCY AND EFFECT ON LEFT
VENTRICULAR FUNCTION
Line Lottonen, Mari Merentie, Jenni Huusko, Riina Rissanen, Seppo Ylä-Herttuala
Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences,
University of Eastern Finland
Severe coronary artery disease is a leading cause of death in developed countries
and angiogenic gene therapy is studied as a promising new approach in treating
myocardial ischemia in no-option patients. Here we tested the myocardial
transduction  efficiency  of  adeno-associated  virus  mediated  gene  transfer  and  its
effects on left ventricular function and myocardial morphology. Adeno-associated
virus serotype 2 (AAV-2) mediated LacZ gene transfer was done under ultrasound
guidance to the anterior wall of left ventricle in mice. Left ventricular function and
ECG were followed in several time points up to three months after the gene
transfer. Myocardial morphology, inflammation, scar tissue formation and
transduction efficiency of the virus were analyzed from histological samples in
three different end points after the gene transfer. Transduction efficiency of AAV-2
in mouse myocardium was good. Ejection fraction started to decrease a month
after the injection probably due to moderate inflammation and scar tissue
formation in heart. We conclude that in terms of transduction efficiency, AAV-2
seems to be a good vector candidate for myocardial gene transfer but its harmful
side effects need to be further studied.
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LENTIVIRAL PROTEIN TRANSDUCTION WITH GENOME-MODIFYING
INTEGRASE-I-PPOI FUSION PROTEIN
Vesa Turkki [1,2], Diana Schenkwein [1,2], Mervi Ahlroth [3], Seppo Ylä-Herttuala [1]
[1]Department of Molecular Medicine and Biotechnology, AIVI, University of Eastern Finland; [2]Ark
Therapeutics group Plc.; [3]Suomen Reumaliitto Ry
In  addition  to  gene  transfer,  lentiviral  vectors  can  also  be  harnessed  for  protein
transduction purposes. We have previously presented a cis-packaging method for
foreign protein incorporation into lentiviral vectors while retaining the gene
transfer activity. Here we demonstrate the principle of cis-packaging application
in genome editing using I-PpoI meganuclease fused to lentiviral integrase. Third
generation self-inactivating lentiviral vectors were produced in 293T cells with
standard cotransfection of four plasmids, one of which contained the I-PpoI cDNA
fused  C-terminal  to  integrase  in  the  gag-pol  sequence.  Correct  packaging  of  the
fusion  protein  and  its  ability  to  cut  target  sequence  were  verified.  The  fusion
protein was able to enter the nucleus and cause double-strand breaks. We also
found that cancer cell lines recover ineffectively from the meganuclease-induced
double-strand breaks, whereas non-cancerous cells suffer no loss of viability.
Remarkable cytotoxicity of IN-I-PpoI LVV for cancer cells lines in vitro led to the
testing of the fusion protein in vivo, where the effect was preserved and growth of
subcutaneous  tumours  in  nude  mice  was  restricted  with  an  efficiency  similar  to
well-studied thymidine kinase transgene combined with ganciclovir injections.
ENDOTHELIAL LIPASE IS REGULATED BY STEROL REGULATORY
ELEMENT-BINDING PROTEINS (SREBPs) IN ENDOTHELIAL CELLS
Marike H. Dijkstra, Annukka M. Kivelä, Suvi Heinonen, Erika Gurzeler, Suvi Jauhiainen, Seppo
Ylä-Herttuala
Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute, University of Eastern Finland,
Kuopio, Finland
Endothelial lipase (EL) is a member of the lipoprotein lipase family which is
mainly synthesized by endothelial cells (ECs). The main substrate for EL is high-
density lipoprotein (HDL) and inverse correlation between HDL-cholesterol
(HDL-C) levels and EL has been well established. As sterol regulatory element-
binding proteins (SREBPs) are well known regulators of genes involved in lipid
metabolism  we  hypothesized  that  SREBPs  regulate  EL  in  ECs  and  that  EL
expression  can  be  modified  by  the  SREBP  activator  VEGF-A.  Western  blot  and
quantitative PCR results showed SREBP2 up regulation and activation by
starvation increased EL levels in HUVECs. Inhibition of the SREBP pathway by
several inhibitors or siRNA confirmed the role of SREBPs in EL regulation. VEGF-
A treatment of HUVECs inhibited EL expression via SREBPs in vitro, suggesting a
possible mechanism for increased circulating HDL-C levels in atherosclerotic LDL-
R/ApoB double knockout mice after adenoviral VEGF-A treatment in vivo. These
data indicate that SREBPs are novel regulators of EL expression in ECs. Moreover,
VEGF-A treatment induced a beneficial lipid profile in vivo by increasing systemic
HDL-C levels possibly mediated by inhibition of EL expression via SREBPs.
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NRF2 DEFICIENCY IN LDL-RECEPTOR DEFICIENT MICE EXPRESSING
ONLY APOB100 LEADS TO SEVERE ATHEROSCLEROSIS AND OCCLUSIVE
CORONARY ARTERY DISEASE
Anna-Kaisa Ruotsalainen, Mari Merentie, Mervi Partanen, Line Lottonen, Seppo Ylä-Herttuala,
Anna-Liisa Levonen
Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences,
University of Eastern Finland, FIN-70211, Kuopio, Finland
Oxidative  stress  is  an  imbalance  of  reactive  oxygen  species  (ROS)  and  has  an
important role in the progression of atherosclerosis. Transcription factor NF-E2-
related factor 2 (Nrf2) is a positive regulator of many antioxidant and detoxifying
enzymes and thereby affording cytoprotection also in  the cardiovascular  system.
Contradictory to its antioxidant and anti-inflammatory effects, the loss of Nrf2 in
Apo E-deficient mice alleviates atherosclerosis likely via combined systemic and
local  effects.  For  this  reason,  we  sought  to  determine  the  role  of  Nrf2  in
atherosclerosis in a mouse model that more closely mimics human
hypercholesterolemia, the LDL-receptor deficient mice expressing apoB100-only
(LDLR-/-ApoB100). Remarkably, our preliminary data demonstrated that Nrf2
deficiency  increased  the  lesion  area  in  aortic  root  and  occlusive  coronary  artery
disease in LDLR-/-ApoB100 mice. In addition, Nrf2-/-LDLR-/-ApoB100 mice
developed spontaneous myocardial infarction between the age of 5-11 months on
a chow diet,  with respective worsening of  left  ventricular  function.  We conclude
that Nrf2 deficiency possibly leads to severe atherosclerosis, occlusive coronary
artery disease and subsequent myocardial infarction in LDLR-/-ApoB100 mice. This
phenotype provides a new model for coronary artery disease and preclinical
testing of novel therapies.
EFFECT OF SOLUBLE VASCULAR ENDOTHELIAL GROWTH FACTOR 3
(sVEGFR3) ON ATHEROGENESIS IN LDLR-/-/APOB100/100 MOUSE MODEL
Taina Vuorio [1], Suvi Heinonen [1], Jere Pikkarainen [1], Kari Alitalo [2], Seppo Ylä-Herttuala [1]
[1] Department of Biotechnology and Molecular Medicine, University of Eastern Finland; [2] Molecular Cancer
Biology Program, Haartman Institute, University of Helsinki
Lymphatic vessels collect and transport extravasated fluid from tissues to blood
stream and participate in fat metabolism by taking up chylomicrons from
intestinal microvilli. They are also present in outer layers of large arteries and
therefore might play a role in arterial pathologies, such as atherosclerosis. In this
study, mice expressing soluble VEGFR3, a molecule inhibiting normal lymphatic
vessel development and function, was cross-bred with atherosclerotic LDLR-/-
/ApoB100/100 mice. Both female and male mice were selected from age groups 3-4
months, 7-8 months and 11-12 months and LDLR-/-/ApoB100/100 mice served as
controls. Mice were fed with western-type high-fat diet (42% of calories from fat
and  0.15%  from  cholesterol)  up  to  3  months  and  blood  samples  were  collected
every two weeks. Plasma triglyceride and cholesterol levels were measured to
analyze the lipid metabolism of the mice. Atherosclerosis was quantified from
Sudan IV staining of en face aortas and hematoxylin-eosin staining of aortic roots.
Effects of the impaired lymphatic vessel function on the development of
atherosclerosis will be described.
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GENDER-SPECIFIC MECHANISM OF SYNAPTIC IMPAIRMENT AND ITS
PREVENTION BY GCSF IN A MOUSE MODEL OF AMYOTROPHIC
LATERAL SCLEROSIS
E Pollari [1], N Naumenko [1], A Kurronen [1], R Giniatullina [1], A Shakirzyanova [1,2], J Magga
[1], J Koistinaho [1], R Giniatullin [1]
[1]  A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland; [2] Kazan Institute of
Biochemistry and Biophysics KSC RAS, Kazan, Russia
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease of
motoneurons which progresses differentially in males and females for unknown
reason. Our aim was to measure electrophysiologically pre- and post-synaptic
properties of neuromuscular junction in diaphragm of an ALS mouse model at
early symptomatic stage and determine whether sex or anti-inflammatory
treatment with granulocyte colony stimulating factor (G-CSF) affects the
properties of synaptic transmission or level of reactive oxygen species (ROS) in
spinal  cord.  Miniature  and  evoked  endplate  potentials  (MEPPs  and  EPPs)  were
recorded in the diaphragm muscle using intracellular microelectrode technique.
Electrophysiological testing revealed that in ALS mice the postsynaptic function
was mainly preserved whereas the presynaptic properties were greatly affected by
the disease. In male mice the G-CSF treatment improved the affected presynaptic
properties. In the spinal cords the level of ROS was increased in males but not in
females and was reduced by G-CSF treatment. This is the first detailed
electrophysiological analysis of impaired synaptic function in a mouse model of
ALS providing a sensitive biomarker for ALS research. Our results support
previous findings of sexual dimorphism in ALS progression and drug response.
INTERLEUKIN-33 DIMINISHES THE LESION SIZE IN THE MOUSE MODEL
OF PERMANENT ISCHEMIA
Paula Korhonen, Tarja Malm and Jari Koistinaho
Department of Neurobiology, A.I. Virtanen Institute of Molecular Sciences, University of Eastern Finland
Cerebral stroke is one of the leading causes of death and long-term disability in the
world.  Central and peripheral inflammatory responses contribute to the outcome
after ischemia; Th1-shifted responses contribute to neuronal death whereas Th2-
type responses are generally beneficial. IL-33 is recently found cytokine that shifts
immune balance towards Th2-phenotype via anti-inflammatory cytokines IL-4, IL-
5 and IL-13. IL-33 has been shown to be protective in atherosclerosis but there are
no studies of IL-33 in brain diseases. The aim of this study was to test whether IL-
33 is protective in a mouse model of ischemic stroke. Balb/c mice were treated
with IL-33 a week before permanent middle cerebral artery occlusion, with a dose
of 1 μg given twice a week i.p. Blood samples were taken from the saphenous vein
before  and  after  ischemia.  The  mice  were  imaged  by  MRI  and  sacrificed  3  days
post ischemia. Cytokine levels in plasma and spleen were determined by flow
cytometry. Pretreatment with IL-33 decreased the ischemic damage significantly
(p<0.05)  and  increased  the  expression  of  several  cytokines,  including  IL-4  in
plasma and spleen. It is concluded that IL-33 regulates the extent of infarction after
ischemic stroke and may represent a novel therapy for neurodegenerative
diseases.
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INTRA-ARTERIAL INFUSION OF HUMAN BONE MARROW DERIVED
MESENCHYMAL CELLS RESULTS IN TRANSIENT ENTRAPMENT IN THE
BRAIN AFTER CEREBRAL ISCHEMIA IN RATS
Bhimashankar Mitkari [1], Erja Kerkelä [2], Johanna Nystedt [2], Matti Korhonen [2], Tuulia
Huhtala [3], Jukka Jolkkonen [1]
[1] Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio; [2] Finnish Red Cross
Blood Service, Helsinki; [3] AIV Institute, University of Eastern Finland, Kuopio
Cell therapies from various sources have been under intense research. Efficient
homing  of  the  cells  in  the  injured  brain  without  complications  is  necessary  to
facilitate therapeutic potential of cell therapy. Intra-arterial infusion of cells
bypasses  the  filtering  organs  and  directs  the  cells  to  the  target  area.  Here  we
studied biodistribution of human bone marrow derived mesenchymal cells
(BMMSC)  after  infusion  through  external  carotid  artery  in  rats  subjected  to
transient middle cerebral artery occlusion (MCAO). Transient MCAO was induced
in male Wistar rats followed by intra-arterial injection of BMMSCs. Cells were
cultured without animal-derived reagents and treated with a proteolytic enzyme
to transiently modify certain cell adhesion proteins. Biodistribution of 111In-oxine
labeled cells were then studied by SPECT imaging immediately after injection and
24 h thereafter. Intra-arterial infusion through the external carotid artery was safe
and efficient administration route resulting in a massive but transient entrapment
of cells in the brain. Eventually most of the cells relocated into the internal organs.
Thus,  more  work  is  needed  to  understand  the  functional  role  and  mechanisms
involved in long-term cell engraftment in ischemic brain.
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REGULATION OF INSULIN SECRETION IN SULFONYLUREA RECEPTOR 1
KNOCK-IN MOUSE
Nagendra Yaluri, Shalem Modi, Maykel López Rodriquez, Marc Cerrada-Gimenez, Markku Laakso
Internal Medicine, University of Eastern Finland, Kuopio
We have previously described a new subtype of autosomal dominant diabetes in a
Finnish family attributable to a dominant heterozygous mutation E1506 in the
sulphonylurea  receptor  1  gene  (SUR1).   Interestingly,  this  mutation  causes
congential hyperinsulinism in infancy, loss of insulin secretory capacity in early
adulthood, and diabetes in middle age. We ‘knocked-in’ this SUR1/E1506K
human mutation in mice aiming to investigate the molecular mechanisms of this
mutation on the regulation of insulin secretion.  We also performed experiments
using  the  MIN6  cell  lines.  We  observed  that  the  pancreatic  islets  of  the
SUR1/E1506K mice do not respond normally to glucose and incretin (GLP-1)
stimulation. The 1st phase of insulin secretion was decreased due to lower protein
expression and activity of EPAC-2. We demonstrated that the hyperinsulinemia
during infancy is likely caused by a cross-talk between two different insulin
pathways regulating insulin secretion, namely the ATP dependent potassium
channels hyperactivated by the mutation, and the cholinergic pathway, since the
islets were hypersensitive to acetylcholine. Both pathways (but mainly the
cholinergic pathway) lead to an increase in calcium influx into the beta-cells. High
intra-cellular calcium levels and a subsequent activation of other regulatory
pathways lead to a decrease in TRPM5 expression, and an increase in osteopontin
gene expression, which further impair insulin secretion at later stages of diabetes.
HIPPOCAMPAL VOLUME, TENSOR-BASED MORPHOMETRY AND
VOXEL-BASED MORPHOMETRY IN FRONTOTEMPORAL DEMENTIA
MA Muñoz [1], P  Hartikainen [1,2], J Koikkalainen [3], R Wolz [4], V Julkunen [1,2], E Niskanen
[5], S-K Herukka [1,2], M Kivipelto [1,6], R Vanninen [5], D Rueckert [4], J Lötjönen [3], and H
Soininen [1,2]
[1] Institute of Clinical Medicine, Neurology, University of Eastern Finland; [2] Department of Neurology,
Kuopio University Hospital; [3] VTT Technical Research Centre of Finland; [4] Department of Computing,
Imperial College London; [5] Department of Radiology, Kuopio University Hospital; [6] Karolinska Institute
Introduction & objective: MRI is an important clinical tool for diagnosing
dementia diseases. However there is a need of finding a more accurate and
standardized method. We compare Frontotemporal Dementia (FTD) with
Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI) stages using
automatic MRI analysis methods: Hippocampal Volumetry (HV), Tensor-based
Morphometry (TBM) and Voxel-based Morphometry (VBM), in specific regions of
interest in order to find the highest accuracy. Methods: Thirty-seven FTD patients,
46 AD patients, 26 control subjects (C), 16 patients with progressive MCI (P-MCI)
and 48 patients with stable-MCI (S-MCI) were included in the analyses. We
calculated the Correct Classification Accuracy (CCR), sensitivity (SS) and
specificity (SP) between the study groups. Results: We found significant results
differentiating FTD from C with HV (hippocampus left side) (CCR=0.83; SS=0.83;
SP=0.82), with TBM (hippocampus and amygdala) (CCR=0.83; SS=0.96 SP=0.72),
and with VBM (all the regions studied, especially in hippocampus and amygdala)
(CCR=0.86;  SS=0.96;  SP=0.78).  VBM  achieved  the  highest  accuracy  in
differentiating FTD and AD (CCR=0.74; SS=0.78; SP=0.70). Conclusion: VBM
resulted in highest accuracy in differentiating between FTD and AD.
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CORTICAL SPREADING DEPRESSION INVESTIGATED USING SPIN-
LOCK FUNCTIONAL MAGNETIC RESONANCE IMAGING
Joonas Autio, Artem Shatillo, Olli Gröhn
A.I. Virtanen Institute, Department of Neurobiology, University of Eastern Finland
Functional magnetic resonance imaging (fMRI) is based on the blood oxygen level-
dependent (BOLD) contrast. However, because MRI signal is not only sensitive to
BOLD contrast but also to tissue homeostasis, we hypothesized that intense
metabolic events may cause endogenous tissue relaxation changes detectable with
fMRI.  Cortical  spreading  depression  (CSD)  was  used  as  a  suitable
pathophysiological paradigm to evoke strong but transient homeostatic
disturbances. The underlying fMRI signal changes during CSD were investigated
using cerebral blood volume (CBV)-weighted fMRI and spin-lock RF-technique
that attenuate blood and the extra-vascular BOLD signals, respectively, with an
aim to detect changes in endogenous tissue signals. Our results show substantial
differences between CBV-weighted and SL-weighted signals indicating that fMRI
signal is modulated by endogenous tissue contrast. Our preliminary results
suggest a new concept: BOLD-contrast is an inadequate model to fully describe
fMRI signals during strong pathophysiological paradigms. The mechanisms of the
endogenous tissue contrast remain elusive.
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INTERFERON  SENSITIVITY OF TUMOR CELLS CORRELATES WITH
POOR RESPONSE TO VA7 VIROTHERAPY IN MOUSE GLIOMA MODELS
Janne Ruotsalainen [1], Miika Martikainen [1], Minna Niittykoski [1], Tuulia Huhtala [1], Tytti
Aaltonen [2], Jari Heikkilä [2], John Bell [3], Markus Vähä-Koskela [3], Ari Hinkkanen [1,4]
[1] A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland; [2]
Department of Biochemistry, Åbo Akademi University, Turku, Finland; [3] Ottawa Hospital Research Institute,
Ottawa, Canada; [4] Cancer Center of Eastern Finland
In our recent study replicative alphaviral vector VA7 was very effective against
orthotopic human U87-glioma in vivo model.  We  tested  here  VA7  efficacy  in
immunocompetent orthotopic GL261 and CT-2A glioma models of C57BL/6
mouse. Despite general in vitro susceptibility, GL261 infection was highly
restricted in confluent cell cultures and mouse IFN pretreatment prevented VA7
replication in both cell lines. When mice bearing orthotopic GL261 or CT-2A
tumors were administered neurotropic VA7, either intravenously or intracranially,
the vector  was unable  to  infect  the tumor and no survival  benefit  was achieved.
Pre-treatments with CPA and rapamycin had no effect on tumor infection or
survival. Intracranial GL261 tumors were refractory also in athymic C57BL/6
mice, which have serious defects in their adaptive immunity. Implanted VA7
preinfected GL261 cells also developed tumors excluding participation of physical
barriers  and  indicating  robust  host  interferon  action.  Mouse  and  human  IFN
seem not to be species cross-reactive, which might limit the translational relevance
of xenograft models in oncolytic virotherapy. In our pilot experiments, valproic
acid demonstrated efficacy in combination with VA7 in GL261 model doubling the
survival.
THE EFFECT OF KNOCKDOWN OF XIAP IN A SWITCH FROM TYPE II TO
TYPE I TRAIL SIGNALING IN HUMAN FOLLICULAR LYMPHOMA CELLS
J Adem, U Nuutinen, A Ropponen, J Pelkonen
Institute of Clinical Medicine, Department of Clinical Microbiology, University of Eastern Finland
Follicular lymphoma (FL) is a common type of non-Hodgkin Lymphoma (NHL). It
is not curable and the median survival of FL patients is eight to ten years. The anti-
apoptotic Bcl-2 family proteins protect FL cells from apoptosis (a programmed cell
death) by keeping mitochondrial integrity from a variety of apoptotic stimuli.
Based on Bcl-XL overexpression  studies  in  human  FL  cell  lines,  we  have  shown
that TRAIL induces apoptosis through type I apoptotic signaling (mitochondrial
independent) or type II apoptotic signaling (mitochondrial dependent) pathways.
We have also found that in Bcl-XL overexpressing type II cells, TRAIL induced
partial processing of caspase-3 whereas, the presence of a proteasome inhibitor
MG-132 led to the full activation of caspase-3 and switched type II signaling to
type I signaling. The switch of type II to type I apoptotic signaling helps to
overcome the resistance of  FL and other  lymphomas against  cancer  therapy.  We
propose that X-linked inhibitory of apoptosis protein (XIAP), a potent suppressor
of  apoptosis  prevents  full  activation  of  caspase-3.  At  present,  we  examine  the
effect  of  regulated  knockdown  of  XIAP  using  lentiviral  vector,  pSLIK  (Single
Lentivector for inducible knockdown) to investigate the role of XIAP in the switch
of the signaling pathway.
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CHARACTERIZATION OF hNPC DERIVED FROM hES AND hiPS CELLS
INJECTED INTO INTACT AND INJURED SPINAL CORD
I. Kidin, Y. Pomeshchik, K. Puttonen, M. Ruponen, T. Malm, O. Hovatta and J. Koistinaho
Department of Neurobiology, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland
Transplantation of human neural progenitor cells (hNPCs) is thought to represent
a  promising  novel  approach  in  treating  the  spinal  cord  injury  (SCI).  However,
human  embryonic  stem  (hES)  cells  as  a  source  of  hNPCs  has  quantitative,
immunological and ethical restrictions. These limitations can be overcome by the
application of human induced pluripotent stem (hiPS) cells. To investigate the
survivability, migration and differentiation potential of hES- and hiPS-derived
hNPCs, the cells were labeled with lenti-GFP and injected into the intact or injured
(only hES) spinal cord of C57BL/6J mice after T10 laminectomy and/or contusion
SCI. Seven days after transplantation, the mice were sacrificed and spinal cords
were dissected for immunohistochemical analysis. Transplanted cells survived
and migrated along the intact and injured spinal cords. The transplanted cells did
not express pluripotent marker Nanog, asrocyte marker GFAP, microglial marker
Iba1 or neuronal marker Tuj1. Instead, GFP+ cells were positive for DCX and Ki-67,
markers of neurogenesis and cell proliferation. Our results show that grafted
hNPCs derived from hiPS and hES cells are actively dividing and proliferating
cells  which  survive  at  least  up  to  7  days  in  intact  and  injured  SC.  Whether
transplantation of hiPS-derived hNPC into the injured spinal cord is beneficial,
remains to be investigated.
PREVENTING ATHEROSCLEROSIS WITH IK17-ANTIBODY IN MICE
Antti Määttä [1], Taina Vuorio [1], Hanna Lesch [1], Janne Ruotsalainen [1], Minna Kaikkonen [1],
Joseph Witztum [2], Seppo Ylä-Herttuala [1]
[1] A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland;  [2]
Department of Medicine, University of California San Diego, La Jolla, CA, USA
Atherosclerosis and its clinical symptoms are one of the most common causes of
mortality in Western World. The disease is caused by accumulation on modified
cholesterols and inflammation in arterial walls, causing eventually complete
blockage of an artery. IK17 is a single chain antibody(ScFv) against oxLDL. Short
term expression of IK17 has been shown to reduce atherosclerotic plaques. Goal of
our study was to investigate the effects of long term expression of IK17 in mouse
models. We created transgenic(Tg) mice expressing IK17 under apoE-promoter
and crossbred them to  LDLR-/- mice. Secondly, to study the macrophage specific
effects of IK17-expression irradiated LDLR-/- mice were also transplanted with
bone marrow of IK17-Tg-mice. The mice were kept on high fat diet for 12 weeks.
The cross-sectional area of the aortic root and the lesion coverage of the aorta were
assessed.  We  produced  a  novel  IK17-ScFv-Tg-mouse  model  to  study  the
therapeutic effects of long term anti-oxLDL antibody production in the treatment
of atherosclerosis. Throughout the study, we detected IK17 from the serum of Tg-
mice in high levels. Preliminary results from bone marrow transplantation studies
showed that  macrophage-specific  expression of  IK17 is  enough to  reduce lesions
size in heart leaflets.
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SELECTION OF TUMOR AND TUMOR VASCULATURE SPECIFIC
ANTIBODIES FROM PHAGE DISPLAY LIBRARY AND THEIR GENETIC
DELIVERY IN VIVO
Emmi Kokki, Thomas Wirth, Seppo Ylä-Herttuala
 Department of Biotechnology and Molecular Medicine, A. I. Virtanen Institute, University of Eastern Finland
Monoclonal antibodies hold great promises for cancer treatment but there are still
some remarkable limitations (i.e. high cost, non-stable plasma concentration and
side effects) in current antibody therapies. Genetic delivery of therapeutic
antibodies can solve many of these problems. The aim of this study is to find new
tumor and tumor vasculature specific antibodies and achieve stable and long-term
gene expression in vivo using a single administration of a lentiviral vector
expressing  a  therapeutic  antibody.  For  that  we  are  constructing  a  human  scFv
phage display library using blood samples of cancer patients. The constructed
library will be screened in vivo using three different animal models with highly
vascularised tumors. Variable regions of heavy and light chains of selected
antibodies will be cloned into lentiviral vector and administered to tumor bearing
animals. We will study the ability of antibody expressing lentiviral vector to
suppress tumor growth aiming at high, long-lasting and stable gene expression.
Study results are expected to be beneficial in cancer treatment, diagnostics and
drug targeting to tumors or tumor vasculature.
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